Literature DB >> 17890492

Comparison of methods for assessing abdominal adipose tissue from magnetic resonance images.

Hassan Arif1, Susan B Racette, Dennis T Villareal, John O Holloszy, Edward P Weiss.   

Abstract

OBJECTIVE: To compare the inter-rater and intra-rater reliability and analysis time of two methods for quantifying visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) volumes from magnetic resonance (MR) images. RESEARCH METHODS AND PROCEDURES: Ten subjects (BMI, 27.0 +/- 2.1 kg/m(2); 56 years of age +/- 4 years) underwent MR imaging of the abdomen. Ten transverse T1-weighted images were selected from each scan and analyzed using two software packages that differ in principle. The first method, ANALYZE version 5.0, represents the manual threshold method, and the second, HIPPO version 1.3, is based on the fuzzy clustering approach. Inter-rater reliability for each method was assessed by comparing the intra-class correlation coefficients (ICCs) for VAT and SAT results from two evaluators, and intra-rater reliability for each method was assessed by comparing ICCs for VAT and SAT analyses performed 1 week apart by the same evaluator. The total time for analysis also was compared between methods.
RESULTS: The inter-rater reliability for VAT was greater with HIPPO than with ANALYZE (ICC = 0.996 vs. 0.828), whereas inter-rater reliability for SAT did not differ between methods (ICC = 0.975 and 0.987). The intra-rater reliability was equally high with HIPPO and ANALYZE for both VAT (ICC = 0.998 vs. 0.992) and SAT (ICC = 0.996 vs. 0.992). HIPPO required less than one-half as much analysis time as ANALYZE (15.9 +/- 4.4 vs. 36.5 +/- 8.2 minutes, p < 0.0001). DISCUSSION: HIPPO software appears advantageous for the quantification of VAT from multislice MR images because inter-rater results are more reliable, and it is more time-efficient than less automated methods.

Mesh:

Year:  2007        PMID: 17890492     DOI: 10.1038/oby.2007.266

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

1.  Preferential reductions in intermuscular and visceral adipose tissue with exercise-induced weight loss compared with calorie restriction.

Authors:  Joan C Murphy; Jennifer L McDaniel; Katherine Mora; Dennis T Villareal; Luigi Fontana; Edward P Weiss
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

2.  Effect of weight loss, exercise, or both on cognition and quality of life in obese older adults.

Authors:  Nicola Napoli; Krupa Shah; Debra L Waters; David R Sinacore; Clifford Qualls; Dennis T Villareal
Journal:  Am J Clin Nutr       Date:  2014-04-30       Impact factor: 7.045

3.  Effect of Aerobic or Resistance Exercise, or Both, on Intermuscular and Visceral Fat and Physical and Metabolic Function in Older Adults With Obesity While Dieting.

Authors:  Debra L Waters; Lina Aguirre; Burke Gurney; David R Sinacore; Kenneth Fowler; Giulia Gregori; Reina Armamento-Villareal; Clifford Qualls; Dennis T Villareal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-01-07       Impact factor: 6.053

4.  Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.

Authors:  Edward P Weiss; Dennis T Villareal; Luigi Fontana; Dong-Ho Han; John O Holloszy
Journal:  Aging (Albany NY)       Date:  2011-05       Impact factor: 5.682

5.  Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial.

Authors:  M Bouchonville; R Armamento-Villareal; K Shah; N Napoli; D R Sinacore; C Qualls; D T Villareal
Journal:  Int J Obes (Lond)       Date:  2013-07-04       Impact factor: 5.095

6.  A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis.

Authors:  Kathryn A Murray; Caroline L Hoad; Jill Garratt; Mehri Kaviani; Luca Marciani; Jan K Smith; Britta Siegmund; Penny A Gowland; David J Humes; Robin C Spiller
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.